SCYNEXIS, Inc. (SCYX)
0.645
-0.01
(-0.94%)
USD |
NASDAQ |
Dec 09, 16:00
0.6376
-0.01
(-1.15%)
Pre-Market: 20:00
SCYNEXIS EPS Diluted (Quarterly): -0.1722 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.591M |
| Revenue (Quarterly) | 0.334M |
| Total Expenses (Quarterly) | 8.925M |
| Enterprise Value | -8.656M |
| Profit Margin (Quarterly) | -2.57K% |
| Earnings Yield | -83.15% |
| Normalized Earnings Yield | -102.11 |